Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Editorial team
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Lab21 appoints group director Lab21 appoints group director Of quality, regulatory affairs and operations excellence Gentronix expands sales teams in US and Europe Gentronix expands sales teams in US and Europe Gentronix expands sales teams in US and Europe Appoints Dorothy Zelent and Simon Johns Brian McNamara promoted to division head, Novartis OTC Brian McNamara promoted to division head, Novartis OTC Aims to drive growth in the division Shire receives EURORDIS Award Shire receives EURORDIS Award For its pioneering work in developing treatments for rare diseases Astellas hires senior vp of new Global Medical Affairs division Astellas hires senior vp of new Global Medical Affairs division Charlotte Kremer will be based in Deerfield, Illinois, US Draeger hires new business development manager Draeger hires new business development manager Draeger hires new business development manager Nathan Sanicharane takes up the role Sanofi and Institut Pasteur create awards to support biomedical research Sanofi and Institut Pasteur create awards to support biomedical research Will split €480,000 among four winners AMRI expands quality control leadership AMRI expands quality control leadership Appoints director of quality for aseptic services and senior director of operations at Burlington Freeman Technology formally establishes US subsidiary Freeman Technology formally establishes US subsidiary Freeman Technology formally establishes US subsidiary Appoints Mike Delancy as national sales specialist PM David Cameron opens e-Therapeutics’ drug discovery centre PM David Cameron opens e-Therapeutics’ drug discovery centre PM David Cameron opens e-Therapeutics’ drug discovery centre Network Pharmacology Centre will search for novel treatments for cancer and CNS diseases Wenning to become chairman of Bayer Supervisory Board on 1 October Wenning to become chairman of Bayer Supervisory Board on 1 October Wenning to become chairman of Bayer Supervisory Board on 1 October To succeed Manfred Schneider PRECOS appoints Dr Martin Page as scientific consultant PRECOS appoints Dr Martin Page as scientific consultant Brings oncology experience to Loughborough firm Codexis appoints Peter Strumph as interim ceo Codexis appoints Peter Strumph as interim ceo Special committee will oversee search for a new ceo Call for entries to Rainer Rudolph Foundation prizes Call for entries to Rainer Rudolph Foundation prizes Closing date is 31 March Melbourn promotes Derek Solomon Melbourn promotes Derek Solomon Moves from laboratory manager to operations director Ablynx strengthens management team Ablynx strengthens management team Ablynx strengthens management team Appoints Dr Andreas Menrad as chief scientific officer
  • Previous
  • 1
  • …
  • 163
  • 164
  • 165
  • 166 (current)
  • 167
  • 168
  • 169
  • …
  • 216
  • Next

Trending Articles

  1. New Managing Director for Shimadzu Europa Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
  2. BioDuro appoints Greg Makara to lead discovery chemistry BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
  3. EyeC expands OEM growth with new business development manager Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
  4. Three new commercial appointments for Symbiosis Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
  5. Lonza nominates Pearl Huang to board Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK. Terms and Conditions | Privacy